|
⚲
|
| Keyboard |
| David Gryska | |
|---|---|
| Firm | |
| Address | One World Trade Center Suite 8500 New York, NY 10007 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Mind Medicine Mindmed Inc | 021-545248 | Director | 7.0 M of 7.0 M |
||
| Mind Medicine Mindmed Inc | 021-507913 | Director | 75.0 M of 75.0 M |
||
| Forte Biosciences Inc | 021-489206 | Director | 25.0 M of 25.0 M |
||
| Aerie Pharmaceuticals Inc | 021-225197 | Director | 125.0 M of 125.0 M |
||
| Argos Therapeutics Inc | 021-201905 | Director | 22.0 M of 60.0 M |
||
| Aerie Pharmaceuticals Inc | 021-188624 | Director | 15.0 M of 18.0 M |
||
| Argos Therapeutics Inc | 021-183946 | Director | 16.0 M of 16.0 M |
||
| Argos Therapeutics Inc | 021-177160 | Director | 9.0 M of 50.0 M |
||
| Hyperion Therapeutics Inc | 021-168227 | Director | 7.5 M of 15.0 M |
||
| Hyperion Therapeutics Inc | 021-158551 | Director | 17.5 M of 35.0 M |
||
| Seattle Genetics Inc /WA | 021-131602 | Director | 11.5 M of 11.5 M |
||